Literature DB >> 26144236

Synthesis, purification and crystallographic studies of the C-terminal sterol carrier protein type 2 (SCP-2) domain of human hydroxysteroid dehydrogenase-like protein 2.

Zhong Cheng1, Yao Li1, Chun Sui1, Xiaobo Sun1, Yong Xie1.   

Abstract

Human hydroxysteroid dehydrogenase-like protein 2 (HSDL2) is a member of the short-chain dehydrogenase/reductase (SDR) subfamily of oxidoreductases and contains an N-terminal catalytic domain and a C-termianl sterol carrier protein type 2 (SCP-2) domain. In this study, the C-terminal SCP-2 domain of human HSDL2, including residues Lys318-Arg416, was produced in Escherichia coli, purified and crystallized. X-ray diffraction data were collected to 2.10 Å resolution. The crystal belonged to the trigonal space group P3(1)21 (or P3(2)21), with unit-cell parameters a = b = 70.4, c = 60.6 Å, α = β = 90, γ = 120°. Two protein molecules are present in the asymmetric unit, resulting in a Matthews coefficient of 2.16 Å(3) Da(-1) and an approximate solvent content of 43%.

Entities:  

Keywords:  SCP-2 domian; X-ray diffraction; crystallization; human HSDL2

Mesh:

Substances:

Year:  2015        PMID: 26144236      PMCID: PMC4498712          DOI: 10.1107/S2053230X15008559

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  23 in total

Review 1.  Multifunctionality of human 17beta-hydroxysteroid dehydrogenases.

Authors:  Gabriele Moeller; Jerzy Adamski
Journal:  Mol Cell Endocrinol       Date:  2006-01-04       Impact factor: 4.102

2.  Automated search-model discovery and preparation for structure solution by molecular replacement.

Authors:  Ronan M Keegan; Martyn D Winn
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-03-16

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

Review 4.  Gene structure, intracellular localization, and functional roles of sterol carrier protein-2.

Authors:  A M Gallegos; B P Atshaves; S M Storey; O Starodub; A D Petrescu; H Huang; A L McIntosh; G G Martin; H Chao; A B Kier; F Schroeder
Journal:  Prog Lipid Res       Date:  2001-11       Impact factor: 16.195

5.  17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.

Authors:  Nan-Shan Chang; Lori Schultz; Li-Jin Hsu; Jennifer Lewis; Meng Su; Chun-I Sze
Journal:  Oncogene       Date:  2005-01-20       Impact factor: 9.867

6.  Recognition of a functional peroxisome type 1 target by the dynamic import receptor pex5p.

Authors:  Will A Stanley; Fabian V Filipp; Petri Kursula; Nicole Schüller; Ralf Erdmann; Wolfgang Schliebs; Michael Sattler; Matthias Wilmanns
Journal:  Mol Cell       Date:  2006-12-08       Impact factor: 17.970

7.  In search for function of two human orphan SDR enzymes: hydroxysteroid dehydrogenase like 2 (HSDL2) and short-chain dehydrogenase/reductase-orphan (SDR-O).

Authors:  Dorota Kowalik; Ferdinand Haller; Jerzy Adamski; Gabriele Moeller
Journal:  J Steroid Biochem Mol Biol       Date:  2009-08-22       Impact factor: 4.292

8.  The crystal structure of sterol carrier protein 2 from Yarrowia lipolytica and the evolutionary conservation of a large, non-specific lipid-binding cavity.

Authors:  Federico Perez De Berti; Stefano Capaldi; Raúl Ferreyra; Noelia Burgardt; Juan P Acierno; Sebastián Klinke; Hugo L Monaco; Mario R Ermácora
Journal:  J Struct Funct Genomics       Date:  2013-11-17

9.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  6 in total

1.  Lipid metabolism regulator human hydroxysteroid dehydrogenase-like 2 (HSDL2) modulates cervical cancer cell proliferation and metastasis.

Authors:  Yang Yang; Anna Han; Xinyue Wang; Xianglin Yin; Minghua Cui; Zhenhua Lin
Journal:  J Cell Mol Med       Date:  2021-03-18       Impact factor: 5.310

2.  Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma.

Authors:  Deng-Yong Zhang; Zhong Liu; Zheng Lu; Wan-Liang Sun; Xiang Ma; Pei Zhang; Bin-Quan Wu; Pei-Yuan Cui
Journal:  Onco Targets Ther       Date:  2018-10-17       Impact factor: 4.147

3.  Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma.

Authors:  Jing Zeng; Xiao Ma; Jinjing Wang; Ran Liu; Yun Shao; Yanwei Hou; Zhiyuan Li; Yi Fang
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

4.  Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression.

Authors:  Wen-Bei Liu; He-Li Wang; Lei Chen; Biao Tang; Guolin Ke; Shuai Wang; Yin-Qiao Sun; Junting Ma; Da-Lun Lyu
Journal:  Chin Med       Date:  2022-02-22       Impact factor: 5.455

5.  Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer.

Authors:  Bing Dong; Yang Yang; Anna Han; Songnan Zhang; Zhenhua Lin; Yixuan Wang; Junjie Piao
Journal:  Cancer Manag Res       Date:  2019-07-12       Impact factor: 3.989

6.  Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.

Authors:  Yujia Shi; Zhengdao Mao; Yanhua Huang; Yun Sun; Qi Cao; Xiaowei Yin; Jianan Huang; Qian Zhang
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.